JULIE ATKINS: Open Payments
NPI 1861192437 · ALEXANDER CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 44 payments from 22 companies in 2025. Trend: 2023 $18 · 2024 $0 · 2025 $1,118
Food & beverage: $1,025Education: $93
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 5 | $171 |
| Novartis Pharmaceuticals Corporation | 7 | $164 |
| GENZYME CORPORATION | 2 | $118 |
| Pharmacosmos Therapeutics Inc. | 3 | $71 |
| Novocure Inc. | 3 | $61 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
| Genentech USA, Inc. | 2 | $52 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $44 |
Products named: SARCLISA, KISQALI, JAKAFI, MONOFERRIC, Optune Lua (NovoTTF-200T), LIBTAYO, LUTATHERA, IMFINZI.
Industry payments across AL — which companies pay providers there.
